Stephen Puttick

The Full Court has rejected Medibank's bid to appeal a finding that legal professional privilege did not attach to a Deloitte report commissioned in the wake of a massive data breach.

Medibank has criticised a judge’s finding that legal professional privilege did not attach to a Deloitte report commissioned in the wake of a massive data breach, arguing she came to an “illogical” conclusion. 

The former CEO of Nudie Juice and his wife are fighting a court's ruling in favour of a liquidator's case making breach of duty claims in relation to an alleged tax fraud scheme.

A court has heard that the former CEO of juice company Nudie is "very unwell" and needs more time to file a defence in a case stemming from an alleged fraudulent tax scheme, a week after a judge tossed his summary dismissal bid in a related case.

Allied Pinnacle has partially succeeded in its fight over a commercial lease in Western Sydney, with a judge finding the baked goods supplier did not have to remove its fit out at the conclusion of its lease, but did have to repaint the external walls.

The former CEO of beverage company Nudie and his wife can't escape a liquidator’s case that seeks to void clauses of a settlement that released them from breach of duty claims over an alleged fraudulent tax scheme.

An adjudicator’s finding that it had no jurisdiction to rule on a payment claim in a dispute over a Sydney development was a binding determination under SOPA, an appeals court has said in upholding a decision that a builder’s pursuit of a second, favourable adjudication was an abuse of process.

A judge has ordered the administrator for two class actions over PFAS contamination that settled for $153 million to pay the leftover funds to group members rather than to charities, saying it was not appropriate “to go around making donations”. 

A judge has said there should be a joint initial trial in a class action and the privacy regulator’s case against Medibank over a 2022 cyber attack that exposed the data of almost 10 million customers.

Pharmaceutical giant Johnson & Johnson has denied knowingly selling alleged ineffective medications under its Benadryl, Sudafed and Codral brands, saying research indicated the phenylephrine-containing products worked.